The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Clozapine-Induced Myocarditis and Cardiomyopathy

Cardiac complications of clozapine therapy requiring vigilant monitoring with troponin, CRP, and echocardiography especially in the first month.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Psikiyatri department. Book Appointment →

What is Clozapine-Induced Myocarditis and Cardiomyopathy?

Clozapine carries unique cardiac toxicities distinct from its hematologic risk. Clozapine-induced myocarditis is a relatively rare but potentially fatal hypersensitivity reaction occurring most often in the first 4 weeks of therapy, with peak risk at days 14–22. Estimated incidence varies from 0.7 to 1.2% in some series, with case fatality of 12–30% if not recognized.

The mechanism is believed to be a type I hypersensitivity (IgE-mediated) reaction with eosinophilia and direct cardiomyocyte injury. Risk is increased by rapid titration (especially in Australian and US dosing), age, concomitant valproate, and possibly genetic factors. Clozapine-induced cardiomyopathy is a separate entity occurring later (months to years), often subclinical, characterized by dilated cardiomyopathy and reduced left ventricular ejection fraction.

Monitoring protocols (especially Australian Royal Adelaide protocol) include weekly troponin and CRP for the first 4 weeks, plus baseline and 1 month echocardiography. Suspicion arises with fever, tachycardia, fatigue, dyspnea, chest pain, ECG changes, or rising troponin/CRP. Clozapine cessation is mandatory in confirmed myocarditis; supportive care, beta-blockers, and ACE inhibitors are given. Rechallenge can be considered in select cases with cardiology guidance after full recovery, as clozapine remains uniquely effective in treatment-resistant schizophrenia.

Symptoms

Fever (often early sign)
Tachycardia disproportionate to fever
Fatigue, malaise
Dyspnea
Chest pain or discomfort
Palpitations
Hypotension
Eosinophilia
Elevated troponin
Elevated CRP
ECG abnormalities (ST changes, T wave inversion, conduction delay)
Reduced left ventricular ejection fraction on echocardiography
Heart failure symptoms in cardiomyopathy
Sudden cardiac death (rare)
Pleural or pericardial effusion

Risk Factors

First 4 weeks of clozapine therapy (myocarditis)
Rapid titration (faster than US guidelines)
Concomitant valproate
Older age
Pre-existing cardiac disease
Hypertension, diabetes
Smoking
Obesity, metabolic syndrome
Concurrent infection at initiation
Genetic predisposition (HLA associations under study)
Concomitant SSRI, lithium
High clozapine plasma levels
Months to years on therapy (cardiomyopathy)
Untreated metabolic complications
Sedentary lifestyle

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Fever, tachycardia, malaise in first month of clozapine
  • Chest pain or new dyspnea
  • Heart failure symptoms (orthopnea, edema)
  • Elevated troponin or CRP on routine monitoring
  • ECG changes
  • Reduced exercise tolerance
  • Palpitations or syncope
  • Eosinophilia on blood test
  • Suspected drug reaction with rash, fever
  • Acute illness in patient on clozapine

Treatment Methods

01
Baseline ECG, troponin, CRP, echocardiogram before initiating clozapine
02
Weekly troponin and CRP for first 4 weeks (Australian Royal Adelaide protocol)
03
Patient education on warning symptoms
04
Slow titration following local guidelines (slower in older, frail, sensitive patients)
05
Avoid concomitant valproate where possible during initiation
06
Repeat echocardiography at 1 month and if symptoms
07
Cardiology consultation for any suspicion
08
If myocarditis suspected: stop clozapine immediately and admit
09
Cardiac MRI to confirm myocarditis if available
10
Endomyocardial biopsy in selected severe cases
11
Supportive care: bed rest, oxygen, treat heart failure
12
Beta-blockers, ACE inhibitors, mineralocorticoid receptor antagonists for cardiomyopathy
13
Diuretics for volume overload
14
Restart antipsychotic with another agent (olanzapine, risperidone)
15
Rechallenge with clozapine in carefully selected cases with cardiology, very slow titration
16
Long-term cardiac surveillance with serial echocardiography
17
Address modifiable risk factors (smoking, diabetes, hypertension)
18
Smoking cessation, weight management
19
Routine metabolic monitoring
20
Patient and family education on cardiac warning signs

Which Department to Visit?

You can visit our Psikiyatri department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Psikiyatri Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.